Joint Formulary & PAD

Guideline Profile : Retinal Vein Occlusion

You are here : Home > Formulary Search > Guideline Profile : Retinal Vein Occlusion

Documentation

Guidelines (National)
Retinal Vein Occlusion - NHSE Guidance - December 2025

Drugs

Below are listed all drugs that are used to treat Retinal Vein Occlusion.

Committee Recommendations (0)

  • No records returned.

Guideline Profile

Indication :
Retinal Vein Occlusion
Keywords :
RVO, faricimab, ranibizumab, biosimilar, VEGF, dexamethasone, aflibercept, BRVO, CRVO, central, Branch, intravitreal injection, NICE
Brand Names Include :
Vabysmo, Eylea, Lucentis, Ongavia, Byooviz, Rimmyrah, Ximluci, Afqlir
Important Information :
Latest Additions Date From :
03 Dec 2025
Latest Additions Date To :
31 Dec 2025
Supporting Documents :
1